NCT02872285: A reported trial by Lycera Corp.
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT02872285 |
|---|---|
| Title | A Randomized, Placebo-Controlled, Double-Blind Study to Assess the Efficacy and Safety of LYC-30937-EC in Subjects With Moderate Chronic Plaque-Type Psoriasis |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | Dec. 5, 2016 |
| Completion date | June 22, 2017 |
| Required reporting date | June 22, 2020, midnight |
| Actual reporting date | Jan. 29, 2019 |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | None |